85U-23281-30320
4 vaccinations
3 coded responses
28 check-ins
3 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 640 / MO
- Registered
- 2021-03-14
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-13
Dose 1 — Moderna
-
2021-03-13
Dose 2 — Moderna
-
2021-03-14
Registered in v-safe
-
2021-03-14
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
- 2021-03-15
- 2021-03-17
- 2021-03-18
- 2021-03-19
- 2021-03-20
- 2021-03-27
- 2021-04-03
- 2021-04-10
- 2021-04-17
- 2021-04-24
- 2021-06-12
- 2021-09-11
-
2021-12-06
Dose 3 — Moderna
-
2022-03-13
Survey response — 12 months, dose 2MedDRA: Infection, Menstruation irregular, Polyp, Surgery, Uterine dilation and curettage — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Symptoms: Continuous menstrual bleeding due to polyps and infection, resulting in D&C and change of birth control. · Healthcare visit (other): Outpatient surgeryMedDRA releases: 2024-11 · check-in free text available
-
2022-03-13
Report sent to call center — 12 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-03-16
-
2022-03-24
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2022-06-06
Survey response — 6 months, dose 3MedDRA: SARS-CoV-2 test positive — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Covid home test positive May 8.MedDRA releases: 2024-11 · check-in free text available
-
2022-06-06
Report sent to call center — 6 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-06-07
- 2022-06-07
-
2022-10-22
Dose 4 — Pfizer-BioNTech
- 2022-10-24
- 2022-10-25
- 2022-10-26
- 2022-10-27
- 2022-10-28
- 2022-10-29
-
2022-11-05
Survey response — day 14, dose 4MedDRA: Paranasal sinus hypersecretion, Sinusitis — Feeling: FairFree text: Sinus drainage and infectionMedDRA releases: 2024-11 · check-in free text available
- 2022-11-12
- 2022-11-19
- 2022-11-26
- 2022-12-03
- 2023-01-21
- 2023-04-22
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-13 | Moderna | |
| 2 | 2021-03-13 | Moderna | |
| 3 | 2021-12-06 | Moderna | No |
| 4 | 2022-10-22 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-03-13 | Successful 2022-03-24 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
| 2022-06-06 | Unsuccessful |
Free text
Release 11 — 12 months, dose 2
Symptoms: Continuous menstrual bleeding due to polyps and infection, resulting in D&C and change of birth control.
Healthcare visit (other): Outpatient surgery
Release 11 — 6 months, dose 3
Symptoms: Covid home test positive May 8.
Release 12 — day 14, dose 4
Symptoms: Sinus drainage and infection
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Surgery | · | · | ✓ |
| SD | Infection | · | · | ✓ |
| SD | Menstruation irregular | · | · | ✓ |
| SD | Paranasal sinus hypersecretion | · | · | ✓ |
| SD | Polyp | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
| SD | Sinusitis | · | · | ✓ |
| SD | Uterine dilation and curettage | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release